IRVINE,
Calif., Oct. 24, 2024 /PRNewswire/ -- InMode Ltd.
(Nasdaq: INMD), a leading global provider of innovative medical
technologies, has been granted a preliminary injunction by the U.S.
District Court for the Central District of California in a lawsuit filed against sellers
identified to be the source of unlawful counterfeit sales of
Morpheus8 radiofrequency devices and cartridge
accessories.
On September 3, 2024, the
Honorable Michael Fitzgerald of the U.S. District Court for the
Central District of California
issued the order granting InMode's motion for a preliminary
injunction. InMode's large-scale action against these
illegitimate sellers also warranted a Temporary Restraining
Order (TRO), which was granted due to strong supporting evidence
that it is within the public interest to protect InMode's
trademarks and prevent the sale of counterfeit products,
particularly in this case, where Defendants' counterfeit Morpheus8
products could be sold to unsuspecting third parties for use in
medical procedures. As a result, a court-ordered preliminary
injunction has been issued, freezing various assets, and account
listings of all sellers involved in the sale of the aforementioned
counterfeit goods.
"InMode has zero tolerance for dishonest business practices and
considers the safety of the public its number one priority," said
Moshe Mizrahy, CEO of InMode. "We
will take necessary action with online platforms and sellers
participating in the irresponsible use, sale or distribution of our
brand and counterfeit products associated with it."
InMode will continue to relentlessly pursue enforcement against
sellers of counterfeit InMode products and Morpheus8 devices and
accessories to address the harm and adverse reactions caused by
counterfeit Morpheus8 devices. In the
United States, patients can confirm they are receiving
top-quality care from an InMode provider using a genuine Morpheus8
device by finding an authorized provider at
www.inmodemd.com/find-a-provider.
About InMode
InMode is a leading global provider of innovative medical
technologies. InMode develops, manufactures, and markets devices
harnessing novel radiofrequency ("RF") technology. InMode strives
to enable new emerging surgical procedures as well as improve
existing treatments. InMode has leveraged its medically accepted
minimally invasive RF technologies to offer a comprehensive line of
products across several categories for plastic surgery, gynecology,
dermatology, otolaryngology, and ophthalmology. For more
information about InMode and its wide array of medical
technologies, visit www.inmodemd.com.
Press Contact:
Behrman Cesa Communications
inmode@behrmancesa.com
Investor Contact:
MS-IR LLC
Miri Segal – Scharia
ir@inmodemd.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/inmode-granted-preliminary-injunction-against-online-sellers-prohibiting-counterfeit-sales-of-morpheus8-radiofrequency-devices-and-cartridge-accessories-302285167.html
SOURCE InMode Ltd.
